Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 8,320Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Merck Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Rizatriptan Benzoate

Brand Name : MAXALT

Patent Number : 2060139

Filing Date : 1992-01-28

Strength per Unit : 5mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-28

Date Granted : 1998-12-01

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Rizatriptan Benzoate

Brand Name : MAXALT

Patent Number : 2060139

Filing Date : 1992-01-28

Strength per Unit : 10mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-28

Date Granted : 1998-12-01

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Rizatriptan Benzoate

Brand Name : MAXALT RPD

Patent Number : 2060139

Filing Date : 1992-01-28

Strength per Unit : 5mg

Dosage Form : Wafer

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-28

Date Granted : 1998-12-01

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Rizatriptan Benzoate

Brand Name : MAXALT RPD

Patent Number : 2060139

Filing Date : 1992-01-28

Strength per Unit : 10mg

Dosage Form : Wafer

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-28

Date Granted : 1998-12-01

blank